Registry for children with nonbacterial bone inflammation
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study collects medical information (and imaging results) from children and teens with nonbacterial bone inflammation. It may help doctors better understand how this condition looks on scans and how it’s diagnosed, especially to rule out infection or cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 21 years old or younger when you enroll
- Have an MRI (STIR or T2 fat-saturation view) showing bone swelling within 12 weeks
- Get whole-body imaging (whole-body MRI or a bone scan) as part of the workup
- Have a bone biopsy to rule out infection or cancer unless your pattern is typical, or you have IBD, psoriasis, or palmar-plantar pustulosis
- You should not have a history of, or current, cancer
- You should not have an active bone infection (infectious osteomyelitis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a new MRI scoring system can reliably measure bone inflammation in children with a rare bone disease called CRMO. The goal is to improve how doctors monitor the disease.
This trial tests if zoledronate, a medicine that strengthens bones, can reduce pain in children with CRMO (a condition causing repeated bone inflammation). It compares zoledronate to a placebo (inactive treatment) to see if it helps after 12 weeks.
This study looks at children with joint issues that are not caused by inflammation. It aims to understand different types of joint problems in children and how to diagnose them.
This trial tests whether children with juvenile idiopathic arthritis (JIA) who have been doing well for over a year can safely reduce their medications. The goal is to find the best way to keep arthritis under control while avoiding unnecessary treatments.
This registry collects information about children and teenagers with inflammatory bowel disease (IBD) to help doctors better understand and treat the condition. By joining, you'll help researchers learn more about IBD in young people.
This trial studies a combination of immune-suppressing treatments for children with Crohn’s disease that is not well controlled. It may help reduce inflammation and improve symptoms if you meet the study’s disease-activity and safety requirements.
Hear when a new Chronic Recurrent Multifocal Osteomyelitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.